EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Effects of Cannabidiol on Innate Immunity: Experimental Evidence and Clinical Relevance

Stefano Martini iD, Alessandra Gemma, Marco Ferrari iD, Marco Cosentino iD, Franca Marino

International Journal of Molecular Sciences · 04.02.2023 · 24 (4) · 3125

DOI: 10.3390/ijms24043125 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 04.02.2023. Verfasst von Stefano Martini und 4 weiteren Autor:innen. Beteiligte Einrichtung: Center for Research in Medical Pharmacology, University of Insubria, 21100 Varese, Italy. Hauptthemen laut MEDLINE: Cannabidiol, COVID-19, Cannabis. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 241 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cannabidiol (CBD) is the main non-psychotropic cannabinoid derived from cannabis (Cannabis sativa L., fam. Cannabaceae). CBD has received approval by the Food and Drug Administration (FDA) and European Medicines Agency (EMA) for the treatment of seizures associated with Lennox–Gastaut syndrome or Dravet syndrome. However, CBD also has prominent anti-inflammatory and immunomodulatory effects; evidence exists that it could be beneficial in chronic inflammation, and even in acute inflammatory conditions, such as those due to SARS-CoV-2 infection. In this work, we review available evidence concerning CBD’s effects on the modulation of innate immunity. Despite the lack so far of clinical studies, extensive preclinical evidence in different models, including mice, rats, guinea pigs, and even ex vivo experiments on cells from human healthy subjects, shows that CBD exerts a wide range of inhibitory effects by decreasing cytokine production and tissue infiltration, and acting on a variety of other inflammation-related functions in several innate immune cells. Clinical studies are now warranted to establish the therapeutic role of CBD in diseases with a strong inflammatory component, such as multiple sclerosis and other autoimmune diseases, cancer, asthma, and cardiovascular diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CannabidiolCOVID-19CannabisUnited StatesHumansMiceRatsAnimalsGuinea PigsClinical RelevanceSARS-CoV-2InflammationImmunity, Innate

Stichwörter der Autor:innen

PMNcannabidiolinnate immunity

Substanzen

Cannabidiol

Autor:innen und Institutionen

  • Center for Research in Medical Pharmacology, University of Insubria, 21100 Varese, Italy.

ORCID-Profile: Stefano Martini, Marco Ferrari, Marco Cosentino

Zitieren

APA

Martini, S., Gemma, A., Ferrari, M., Cosentino, M., & Marino, F. (2023). Effects of Cannabidiol on Innate Immunity: Experimental Evidence and Clinical Relevance. International Journal of Molecular Sciences, 24(4), 3125. https://doi.org/10.3390/ijms24043125

Vancouver

Martini S, Gemma A, Ferrari M, Cosentino M, Marino F. Effects of Cannabidiol on Innate Immunity: Experimental Evidence and Clinical Relevance. International Journal of Molecular Sciences. 2023;24(4):3125. doi:10.3390/ijms24043125

BibTeX
@article{Martini2023,
  author = {Martini, Stefano and Gemma, Alessandra and Ferrari, Marco and Cosentino, Marco and Marino, Franca},
  title = {Effects of Cannabidiol on Innate Immunity: Experimental Evidence and Clinical Relevance},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  volume = {24},
  number = {4},
  pages = {3125},
  doi = {10.3390/ijms24043125}
}
Kostenlos starten →